BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25726939)

  • 1. Melan-A positive dermal cells in malignant melanoma in situ.
    Danga ME; Yaar R; Bhawan J
    J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nests with numerous SOX10 and MiTF-positive cells in lichenoid inflammation: pseudomelanocytic nests or authentic melanocytic proliferation?
    Silva CY; Goldberg LJ; Mahalingam M; Bhawan J; Wolpowitz D
    J Cutan Pathol; 2011 Oct; 38(10):797-800. PubMed ID: 21812802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
    Mehregan DR; Hamzavi I
    Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Occult Invasion in Melanoma In Situ.
    Bax MJ; Johnson TM; Harms PW; Schwartz JL; Zhao L; Fullen DR; Chan MP
    JAMA Dermatol; 2016 Nov; 152(11):1201-1208. PubMed ID: 27533878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating neurotized melanocytic nevi from neurofibromas using Melan-A (MART-1) immunohistochemical stain.
    Chen Y; Klonowski PW; Lind AC; Lu D
    Arch Pathol Lab Med; 2012 Jul; 136(7):810-5. PubMed ID: 22742554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
    Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
    J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
    Orosz Z
    Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin.
    Muzumdar S; Argraves M; Kristjansson A; Ferenczi K; Dadras SS
    J Cutan Pathol; 2018 Apr; 45(4):263-268. PubMed ID: 29377259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
    Krengel S; Grotelüschen F; Bartsch S; Tronnier M
    J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX-10 staining in dermal scars.
    Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nodal metastases in melanoma using sox-10.
    Jennings C; Kim J
    Am J Dermatopathol; 2011 Jul; 33(5):474-82. PubMed ID: 21552103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three Types of Nodal Melanocytic Nevi in Sentinel Lymph Nodes of Patients With Melanoma: Pitfalls, Immunohistochemistry, and a Review of the Literature.
    Gonzàlez-Farré M; Ronen S; Keiser E; Prieto VG; Aung PP
    Am J Dermatopathol; 2020 Oct; 42(10):739-744. PubMed ID: 32271206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of Melan-A-positive pagetoid melanocytosis in dysplastic nevi.
    Huwait H; Hijazi N; Martinka M; Crawford RI
    Am J Dermatopathol; 2014 Apr; 36(4):340-3. PubMed ID: 24736669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porcine melanotic cutaneous lesions and lymph nodes: immunohistochemical differentiation of melanocytes and melanophages.
    Grossi AB; Hyttel P; Jensen HE; Leifsson PS
    Vet Pathol; 2015 Jan; 52(1):83-91. PubMed ID: 24503437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.